Comments
Biocon Ltd jumped as much as 5.5 per cent to Rs 251.6, the biggest daily per cent gain since September 25, 2018.
The biotechnology firm posted a 72 per cent jump in June-quarter profit to Rs 206 crore ($29.83 mln), led by growth in the biologics and small molecules businesses.
The Q1 net consolidated profit exceeds analyst estimates of Rs 198 crore, according to Refinitv IBES.
Revenue jumped 30.4 per cent to Rs 1,466 crore. Over 4.7 million shares changed hands, compared with the 30-day average of over 2.99 million shares.
Up to the last close, the Biocon stock had fallen 24 per cent this year ($1 = 69.0580 Indian rupees).
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.